These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 33226078)

  • 1. COVID-19 and cardiovascular diseases.
    Liu F; Liu F; Wang L
    J Mol Cell Biol; 2021 Jul; 13(3):161-167. PubMed ID: 33226078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner.
    Agrawal H; Das N; Nathani S; Saha S; Saini S; Kakar SS; Roy P
    Stem Cell Rev Rep; 2021 Feb; 17(1):94-112. PubMed ID: 33029768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2, Cardiovascular Diseases, and Noncoding RNAs: A Connected Triad.
    Natarelli L; Virgili F; Weber C
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel coronavirus meets the cardiovascular system: Society for Cardiovascular Pathology Symposium 2021.
    Buja LM; Stone JR
    Cardiovasc Pathol; 2021; 53():107336. PubMed ID: 33895311
    [No Abstract]   [Full Text] [Related]  

  • 6. Human Stem Cell Models of SARS-CoV-2 Infection in the Cardiovascular System.
    Ernzen K; Trask AJ; Peeples ME; Garg V; Zhao MT
    Stem Cell Rev Rep; 2021 Dec; 17(6):2107-2119. PubMed ID: 34365591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 and the cardiovascular system.
    Zheng YY; Ma YT; Zhang JY; Xie X
    Nat Rev Cardiol; 2020 May; 17(5):259-260. PubMed ID: 32139904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cells and SARS-CoV-2: An intimate relationship.
    Barbosa LC; Gonçalves TL; de Araujo LP; Rosario LVO; Ferrer VP
    Vascul Pharmacol; 2021 Apr; 137():106829. PubMed ID: 33422689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.
    Ruzzenenti G; Maloberti A; Giani V; Biolcati M; Leidi F; Monticelli M; Grasso E; Cartella I; Palazzini M; Garatti L; Ughi N; Rossetti C; Epis OM; Giannattasio C;
    High Blood Press Cardiovasc Prev; 2021 Sep; 28(5):439-445. PubMed ID: 34173942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Infection and Disease Modelling Using Stem Cell Technology and Organoids.
    Trevisan M; Riccetti S; Sinigaglia A; Barzon L
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones.
    Viveiros A; Rasmuson J; Vu J; Mulvagh SL; Yip CYY; Norris CM; Oudit GY
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H296-H304. PubMed ID: 33275517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection.
    Seltzer S
    Int J Infect Dis; 2020 Dec; 101():42-45. PubMed ID: 32950735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis.
    Seeherman S; Suzuki YJ
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract.
    Galanopoulos M; Doukatas A; Gazouli M
    World J Gastroenterol; 2020 Nov; 26(41):6335-6345. PubMed ID: 33244196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and its impact on COVID-19.
    de Leeuw AJM; Oude Luttikhuis MAM; Wellen AC; Müller C; Calkhoven CF
    J Mol Med (Berl); 2021 Jul; 99(7):899-915. PubMed ID: 33824998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19.
    Shi X; Chen M; Zhang Y
    Mol Biol Rep; 2021 Feb; 48(2):1763-1771. PubMed ID: 33483864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entry, egress and vertical transmission of SARS-CoV-2.
    Zhang H; Zhang H
    J Mol Cell Biol; 2021 Jul; 13(3):168-174. PubMed ID: 33677567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19.
    Maruhashi T; Higashi Y
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Science Underlying COVID-19: Implications for the Cardiovascular System.
    Liu PP; Blet A; Smyth D; Li H
    Circulation; 2020 Jul; 142(1):68-78. PubMed ID: 32293910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE2: from protection of liver disease to propagation of COVID-19.
    Warner FJ; Rajapaksha H; Shackel N; Herath CB
    Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.